Howard Hughes Medical Institute
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Howard Hughes Medical Institute reported 1 stock position worth $466.2 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 100.0% of the portfolio. Compared with Q1 2024, it sold out of 1 and added to 1. The biggest buy was SS SPDR S&P 500 ETF Trust-US (SPY, shares +37%) and the biggest sale an exit from Purecycle Technologies (PCT).
- Most Recent 13F
- Q2 2026
- Location
- Chevy Chase, MD
- CIK
- 0000810386
- Portfolio Value
- $466.2M (Q2 2024)
- SEC Filing
- 0000950123-24-008381 ↗ filed Aug 14, 2024
Holdings Value
Holdings 1 stocks · $466.2M
| SPY SS SPDR S&P 500 ETF Trust-US | 100.00% | 856,663 | $466.2M | Add +36.5% |
Portfolio Sells Q1 2024 → Q2 2024
| PCT Purecycle Technologies Inc. | Sold out | 0.00% | −1.39 |
Portfolio Buys Q1 2024 → Q2 2024
| SPY SS SPDR S&P 500 ETF Trust-US | Add +36.5% | 100.00% | +1.39 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 30 | $445.4M | NVDA, AAPL, GOOGL, MSFT, TSM |
| Q1 2026 | 31 | $415.8M | SPY, NVDA, AAPL, GOOGL, MSFT |
| Q4 2025 | 500 | $174.7M | SPY, NVDA, AAPL, MSFT, AMZN |
| Q3 2025 | 500 | $170.6M | SPY, NVDA, MSFT, AAPL, AMZN |
| Q2 2025 | 501 | $250.9M | SPY, NVDA, MSFT, AAPL, AMZN |
| Q1 2025 | 2 | $202.2M | SPY, BIOA |
| Q4 2024 | 2 | $568.4M | SPY, BIOA |
| Q3 2024 | 2 | $630.4M | SPY, BIOA |
| Q2 2024 | 1 | $466.2M | SPY |
| Q1 2024 | 2 | $332.9M | SPY, PCT |